The Healthcare Team of C▪H▪Reynolds▪Corporate Finance AG led by Stefan Constantin and Markus Kluge successfully advised the stock-listed dsm-firmenich AG on the sale of Pentapharm AG, Switzerland, as well as its Brazilian sister company Pentapharm do Brasil Comércio e Exportação Ltda. Pentapharm is a leading provider of bioactive ingredients for the pharmaceutical, diagnostics and cosmetics industries, employing around 120 people in Switzerland and Brazil.
With this transaction C▪H▪Reynolds once again demonstrated its expertise in successfully managing complex and cross-border carve-out transactions.
C▪H▪Reynolds provided comprehensive support throughout the entire process from preparation and documentation of transaction documents through market phase, due diligence, structuring and negotiation until closing.
You can find the detailed transaction announcement under this link.